Taken together, these findings suggest that HDAC6 overexpression can mitigate neuronal toxicity caused by TDP-43-induced UPS impairment, which may represent a novel therapeutic approach for ALS. This evidence concerns the gene HDAC6 and amyotrophic lateral sclerosis.